Revenues, Recognition and Allowances (Tables)

6 Months Ended

Jun. 30, 2019

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenues

Net revenues for the three and six months ended June 30, 2019 and 2018 were as follows:

	Three months ended June 30,				Six months ended June 30,
	2019		2018		2019		2018
Company product sales	$	17,868	$	14,677	$	30,363	$	27,913
Contract manufacturing sales	388		1,450		930		2,748
Research and development services and other income	85		122		$	170	$	133
Revenue, net	$	18,341	$	16,249	$	31,463	$	30,794

Disaggregated information for the Company product sales revenue has been recognized in the accompanying unaudited interim Condensed Consolidated Statements of Operations, and is presented below according to contract type:

	Three months ended June 30,				Six months ended June 30,
Company Product Sales	2019		2018		2019		2018
Topical	$	12,937	$	7,888	$	21,969	$	15,795
Injectables	4,931		6,789		8,394		12,118
Total	$	17,868	$	14,677	$	30,363	$	27,913

Schedule of Accounts, Notes, Loans and Financing Receivable

The Company's adjustments for the deductions to gross product sales are as follows:

	Three months ended June 30,				Six months ended June 30,
	2019		2018		2019		2018
Gross product sales	$	39,322	$	48,142	$	66,736	$	84,690
Deduction to gross product sales:
Chargebacks and billbacks	11,826		21,449		22,712		38,364
Wholesaler fees for service	2,182		477		3,948		1,112
Sales discounts and other allowances	7,446		11,539		9,713		17,301
Total reduction to gross product sales	$	21,454	$	33,465	$	36,373	$	56,777
Company product sales, net	$	17,868	$	14,677	$	30,363	$	27,913